Matsuo So

504 total citations
24 papers, 298 citations indexed

About

Matsuo So is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Matsuo So has authored 24 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Neurology. Recurrent topics in Matsuo So's work include COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (9 papers) and Respiratory Support and Mechanisms (5 papers). Matsuo So is often cited by papers focused on COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (9 papers) and Respiratory Support and Mechanisms (5 papers). Matsuo So collaborates with scholars based in United States, Japan and Singapore. Matsuo So's co-authors include Toshiki Kuno, Hisato Takagi, Hiroki Kabata, Koichi Fukunaga, Masao Iwagami, Mai Takahashi, Natalia Egorova, Atsuyuki Watanabe, David Steiger and Ryota Inokuchi and has published in prestigious journals such as Journal of Medical Virology, QJM and Respiratory Medicine.

In The Last Decade

Matsuo So

22 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matsuo So United States 10 165 134 95 52 43 24 298
Nicole Waalders Netherlands 5 232 1.4× 141 1.1× 56 0.6× 80 1.5× 43 1.0× 9 365
C K Ng China 5 218 1.3× 144 1.1× 135 1.4× 57 1.1× 48 1.1× 8 413
Luca Sabia Italy 10 118 0.7× 90 0.7× 51 0.5× 70 1.3× 34 0.8× 19 376
Xiaomin Luo China 6 228 1.4× 122 0.9× 44 0.5× 68 1.3× 26 0.6× 7 369
Renhua Sun China 10 130 0.8× 47 0.4× 57 0.6× 56 1.1× 34 0.8× 17 335
Erica Thwaite United Kingdom 4 144 0.9× 178 1.3× 165 1.7× 15 0.3× 57 1.3× 5 337
Namrata Singhania United States 7 128 0.8× 77 0.6× 48 0.5× 34 0.7× 13 0.3× 23 278
Mirko Griesel Germany 5 154 0.9× 83 0.6× 47 0.5× 43 0.8× 27 0.6× 8 266
Yewande Odeyemi United States 7 131 0.8× 99 0.7× 49 0.5× 52 1.0× 35 0.8× 26 231
Emmanuelle Sacco France 5 377 2.3× 253 1.9× 52 0.5× 34 0.7× 25 0.6× 11 533

Countries citing papers authored by Matsuo So

Since Specialization
Citations

This map shows the geographic impact of Matsuo So's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matsuo So with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matsuo So more than expected).

Fields of papers citing papers by Matsuo So

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matsuo So. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matsuo So. The network helps show where Matsuo So may publish in the future.

Co-authorship network of co-authors of Matsuo So

This figure shows the co-authorship network connecting the top 25 collaborators of Matsuo So. A scholar is included among the top collaborators of Matsuo So based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matsuo So. Matsuo So is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agrawal, Abhinav, et al.. (2023). How risky is it to remove an airway stent?. Respiratory Medicine. 216. 107320–107320. 4 indexed citations
2.
So, Matsuo, Udit Chaddha, Samira Shojaee, & Pyng Lee. (2023). Medical thoracoscopy for pleural diseases. Current Opinion in Pulmonary Medicine. 30(1). 84–91. 2 indexed citations
3.
Watanabe, Atsuyuki, Tomohiro Fujisaki, Masao Iwagami, et al.. (2023). Comparison of interventions for intermediate to high‐risk pulmonary embolism: A network meta‐analysis. Catheterization and Cardiovascular Interventions. 102(2). 249–265. 5 indexed citations
4.
So, Matsuo, et al.. (2023). Pulmonary lymphomatoid granulomatosis in a patient with long-term use of a tumour necrosis factor-α inhibitor. BMJ Case Reports. 16(5). e254211–e254211.
5.
Watanabe, Atsuyuki, Matsuo So, Hisato Takagi, et al.. (2022). Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis. Mycopathologia. 187(2-3). 271–289. 20 indexed citations
6.
Watanabe, Atsuyuki, et al.. (2022). Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis. A2959–A2959. 2 indexed citations
7.
Watanabe, Atsuyuki, Matsuo So, Masao Iwagami, et al.. (2022). One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis. Respirology. 27(8). 605–616. 75 indexed citations
8.
So, Matsuo, Hiroki Kabata, Mai Takahashi, Natalia Egorova, & Toshiki Kuno. (2021). The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(4). 265–267. 10 indexed citations
9.
Kuno, Toshiki, Mai Takahashi, Matsuo So, & Natalia Egorova. (2021). The association of anticoagulation before admission and survival of patients with COVID-19. Journal of Cardiology. 79(4). 489–493. 5 indexed citations
10.
So, Matsuo, David Steiger, Mai Takahashi, Natalia Egorova, & Toshiki Kuno. (2021). The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study. Journal of Thrombosis and Thrombolysis. 52(4). 1061–1067. 15 indexed citations
11.
Kuno, Toshiki, Matsuo So, Masao Iwagami, Mai Takahashi, & Natalia Egorova. (2021). The association of statins use with survival of patients with COVID-19. Journal of Cardiology. 79(4). 494–500. 13 indexed citations
12.
Kuno, Toshiki, Yoshihisa Miyamoto, Matsuo So, et al.. (2021). The Association of Timing of Tracheostomy and Survival of Patients with COVID-19. Indian Journal of Otolaryngology and Head & Neck Surgery. 74(S2). 3213–3215. 2 indexed citations
13.
So, Matsuo, Hiroki Kabata, Koichi Fukunaga, Hisato Takagi, & Toshiki Kuno. (2021). Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulmonary Medicine. 21(1). 97–97. 64 indexed citations
14.
Kuno, Toshiki, Matsuo So, Mai Takahashi, & Natalia Egorova. (2021). U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients. Journal of Thrombosis and Thrombolysis. 53(1). 113–117. 9 indexed citations
15.
Kuno, Toshiki, Matsuo So, Mai Takahashi, & Natalia Egorova. (2021). Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid. Journal of Thrombosis and Thrombolysis. 53(2). 352–358. 3 indexed citations
16.
So, Matsuo, Mai Takahashi, Yoshihisa Miyamoto, et al.. (2021). The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 16(1). 102373–102373. 8 indexed citations
17.
Kuno, Toshiki, Matsuo So, Mai Takahashi, & Natalia Egorova. (2021). The association between famotidine and in‐hospital mortality of patients with COVID‐19. Journal of Medical Virology. 94(3). 1186–1189. 8 indexed citations
18.
So, Matsuo, et al.. (2021). Radiological and Functional Lung Sequelae of COVID-19: Systematic Review and Meta-Analysis. A4461–A4461. 2 indexed citations
19.
Kabata, Hiroki, Toshiki Kuno, Hisato Takagi, et al.. (2021). The effect of statins for asthma. A systematic review and meta-analysis. Journal of Asthma. 59(4). 801–810. 15 indexed citations
20.
Satomi, Ryosuke, Mayuko Watase, Matsuo So, et al.. (2019). An Adult Case of Pulmonary Artery Sling Accompanied by Tracheobronchomalacia. Internal Medicine. 58(11). 1621–1624. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026